Sterling Investment Counsel’s Pfizer PFE Stock Holding History

Sterling Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,892	Closed	-$229K	–	168
2023 Q3	$229K	Sell	6,892 -5,304	-43%	-$188K	0.13%	130
2023 Q2	$447K	Sell	12,196 -448	-4%	-$17.4K	0.24%	75
2023 Q1	$516K	Sell	12,644 -3,949	-24%	-$171K	0.31%	62
2022 Q4	$850K	Buy	16,593 +878	+6%	+$42.1K	0.53%	35
2022 Q3	$686K	Sell	15,715 -623	-4%	-$30.3K	0.5%	37
2022 Q2	$855K	Sell	16,338 -550	-3%	-$28K	0.65%	26
2022 Q1	$875K	Buy	16,888 +3,071	+22%	+$159K	0.59%	28
2021 Q4	$816K	Buy	+13,817	New	+$685K	0.55%	32

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sterling Investment Counsel's PFE Position: Q4 2023 in Review

Sterling Investment Counsel sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,892 shares — an estimated $229K sold.

Sterling Investment Counsel first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $875K in Q1 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Sterling Investment Counsel reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Sterling Investment Counsel sold 6,892 Pfizer shares in Q4 2023, an estimated $229K.
Sterling Investment Counsel first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
Sterling Investment Counsel's Pfizer position peaked at $875K in Q1 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Sterling Investment Counsel's 13F filing for Q4 2023, filed 12 Jan 2024.